FY2025 EPS Estimates for Biotricity Lowered by HC Wainwright

Biotricity, Inc. (NASDAQ:BTCYFree Report) – Stock analysts at HC Wainwright decreased their FY2025 EPS estimates for shares of Biotricity in a research report issued to clients and investors on Monday, November 18th. HC Wainwright analyst K. Dede now expects that the company will post earnings of ($0.67) per share for the year, down from their previous forecast of ($0.43). HC Wainwright has a “Neutral” rating on the stock. The consensus estimate for Biotricity’s current full-year earnings is ($0.43) per share.

Biotricity (NASDAQ:BTCYGet Free Report) last released its quarterly earnings data on Monday, August 19th. The company reported ($0.49) earnings per share (EPS) for the quarter. The firm had revenue of $3.20 million for the quarter.

Biotricity Stock Down 11.9 %

Shares of NASDAQ:BTCY opened at $0.37 on Wednesday. The firm has a 50 day moving average of $0.34 and a 200 day moving average of $0.64. The company has a market capitalization of $8.37 million, a price-to-earnings ratio of -0.28 and a beta of 1.22. Biotricity has a 52 week low of $0.19 and a 52 week high of $1.67.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Biotricity stock. AE Wealth Management LLC bought a new stake in Biotricity, Inc. (NASDAQ:BTCYFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned about 0.45% of Biotricity at the end of the most recent reporting period. 3.89% of the stock is currently owned by institutional investors and hedge funds.

Biotricity Company Profile

(Get Free Report)

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Further Reading

Earnings History and Estimates for Biotricity (NASDAQ:BTCY)

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.